Coronavirus Disease 2019 Infection in Children With Sickle Cell Disease: Case Series From Oman
Amal Al Sabahi1, Nawal Al Maskari2, Ibrahim Al Busaidi3
1Department of Paediatric Hematology and Oncology, The National Oncology Centre.
Insights
This study reports on five Omani children with sickle cell disease (SCD) who contracted COVID-19. All pediatric patients with sickle cell disease recovered, highlighting the need for further research on COVID-19 outcomes in this population.
Area of Science:
- Pediatric Hematology
- Infectious Diseases
- Global Health
Background:
- The COVID-19 pandemic poses significant risks to vulnerable populations, including individuals with sickle cell disease (SCD).
- Limited data exist on the impact of COVID-19 on pediatric patients with SCD.
- This study addresses the gap in understanding COVID-19's effects on children with SCD.
Observation:
- A case series of five Omani children diagnosed with sickle cell disease and subsequently infected with COVID-19 is presented.
- The report details the varied clinical presentations, management strategies, and outcomes for these pediatric patients.
- This series provides insights into the specific challenges and responses related to COVID-19 in children with SCD.
Findings:
- All five pediatric patients with sickle cell disease who contracted COVID-19 successfully recovered.
- The case series illustrates diverse clinical manifestations and successful management approaches in this cohort.
- Despite being a high-risk group, the observed pediatric SCD patients showed positive recovery from COVID-19.
Implications:
- The findings suggest that pediatric patients with sickle cell disease may recover from COVID-19, contrary to initial high-risk assumptions.
- Further large-scale studies are crucial to validate these observations and establish definitive conclusions regarding COVID-19 outcomes in pediatric SCD.
- This research contributes to the understanding of COVID-19's impact on pediatric hematological conditions and informs clinical management guidelines.
Background:
In March 2020, WHO announced Coronavirus Disease 2019 (COVID-19) outbreak a global pandemic. During this pandemic, patients with sickle cell disease (SCD) have been placed in the "high-risk" category of the population. Although there are numerous publications describing COVID-19 in adult patients, pediatric data are still limited.
Observation:
Herein, we report case series of 5 sickle cell disease Omani children who got infected with COVID-19; illustrating their different ways of presentation, management and highlighting the outcomes.
Conclusion:
Although SCD patients are considered as a high-risk group, all of the observed patients, and whose cases are reported here, have recovered. A large scale of SCD cases should be studied to reach more conclusive results.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Infectious Diseases and Their Occurrence
Viral Meningitis
Cytomegalovirus Disease
Coronavirus
Respiratory Syncytial Virus Disease


